Christina A Wilson

Christina A Wilson, MD, PhD

Interim Chief, Vascular Neurology Division; Associate Chair Of Education; Neurology Residency Program Director; Vascular Neurology Fellowship Program Director

Department: MD – VASCULAR NEUROLOGY
Business Phone: (352) 273-5550

About Christina A Wilson

Christina Wilson, MD, PhD is an Associate Professor of Neurology at the University of Florida College of Medicine. She serves as the Neurology Residency Program Director, Vascular Neurology Fellowship Director, and Associate Chair of Education for the Department of Neurology. She is also the interim chief of the vascular neurology division and a key member of the only comprehensive stroke program in north central Florida.

Dr. Wilson graduated from Furman University in Greenville, South Carolina, with a bachelor’s degree in psychology. She completed her doctorate degree in pharmacology in 2001 at the University of Pennsylvania, Philadelphia. Her research focused on the cell biology of presenilin proteins associated with Alzheimer’s disease, for which she was awarded a Howard Hughes Medical Institute Predoctoral Fellowship. Dr. Wilson completed her medical degree at the University of Pennsylvania and was an intern in internal medicine at Pennsylvania Hospital, where she was elected Intern of the Year. She then completed her residency in neurology in 2012 at the University of Pennsylvania, and was a neurovascular fellow at the same institution from 2012-2013.

Dr. Wilson joined the faculty of the UF Department of Neurology in 2013 and began as residency program director in 2015. She currently provides stroke care for hospitalized patients and supervises resident continuity clinic. Dr. Wilson also handles didactic training of stroke mechanisms of disease and mentors stroke fellows, medical students and residents. Dr. Wilson’s main interests lie in neurology graduate medical education and clinical stroke management. She is the local primary investigator for several national clinical stroke trials and regularly educates the community and EMS about stroke via outreach events.

Dr. Wilson is a member of the American Stroke Association and American Academy of Neurology.

Accomplishments

Clinical Educator Award
2019 · UF Department of Neurology
Fellow of the American Academy of Neurology (FAAN)
2019 · AAN
Exemplary Teacher Award
2018 · UF College of Medicine
AB Baker Teacher Recognition Award
2017 · American Academy of Neurology
Exemplary Teacher Award
2017 · UF College of Medicine
Didactic Educator Award
2016 · UF Department of Neurology
Exemplary Teacher Award
2016 · UF College of Medicine
Clinical Educator Award
2015 · UF Department of Neurology
Exemplary Teacher Award
2015 · UF College of Medicine
Physician Recognition Award
2015 · UF Health
Exemplary Teacher Award
2014 · UF College of Medicine
Intern of the Year
2009 · Pennsylvania Hospital
Predoctoral Fellow
1995-2000 · Howard Hughes Medical Institute

Teaching Profile

Courses Taught
2018
MDT7090 Elective Topics
2018
MDC7124 Family Med/Geriatrics
2015-2016
GMS6024 Princ Neuroscience 4
2021
MDC7800 Neurology Clerkship

Board Certifications

  • Neurology
    American Board of Psychiatry and Neurology
  • Vascular Neurology
    American Board of Psychiatry and Neurology

Clinical Profile

Specialties
  • Neurology
Subspecialties
  • Vascular Neurology
Areas of Interest
  • Acute Ischemic Stroke
  • Aneurysm
  • Aneurysm in the brain
  • Cerebral aneurysm
  • Stroke
  • Stroke risk factors and prevention
  • Transient ischemic attack

Research Profile

Open Researcher and Contributor ID (ORCID)

0000-0002-6871-6932

Publications

2021
Benefits of an interdisciplinary stroke clinic: addressing a gap in physical therapy at post-stroke neurology follow-up.
Disability and rehabilitation. 1-6 [DOI] 10.1080/09638288.2021.2008527. [PMID] 34871115.
2021
Trends of Acute Ischemic Stroke Reperfusion Therapies from 2012 to 2016 in the United States.
World neurosurgery. 150:e621-e630 [DOI] 10.1016/j.wneu.2021.03.073. [PMID] 33757890.
2020
A double-blind, randomized, controlled study of two dose strengths of dalfampridine extended release on walking deficits in ischemic stroke.
Restorative neurology and neuroscience. 38(4):301-309 [DOI] 10.3233/RNN-201009. [PMID] 32651338.
2020
Updates in the Management of Cryptogenic Stroke and Patent Foramen Ovale.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 40(1):60-66 [DOI] 10.1097/WNO.0000000000000896. [PMID] 31996589.
2019
Predictors of Atrial Fibrillation in Patients With Cryptogenic Stroke.
The Neurohospitalist. 9(3):127-132 [DOI] 10.1177/1941874418819619. [PMID] 31244968.
2019
STN vs. GPi deep brain stimulation for tremor suppression in Parkinson disease: A systematic review and meta-analysis.
Parkinsonism & related disorders. 58:56-62 [DOI] 10.1016/j.parkreldis.2018.08.017. [PMID] 30177491.
2018
Longitudinal Follow-up of Impedance Drift in Deep Brain Stimulation Cases.
Tremor and other hyperkinetic movements (New York, N.Y.). 8 [DOI] 10.7916/D8M62XTC. [PMID] 29607241.
2018
Management of Blunt Cerebrovascular Injury.
Current neurology and neuroscience reports. 18(12) [DOI] 10.1007/s11910-018-0906-7. [PMID] 30353308.
2017
Symptomatic Carotid Occlusion Is Frequently Associated With Microembolization.
Stroke. 48(2):394-399 [DOI] 10.1161/STROKEAHA.116.015375. [PMID] 28077455.
2016
Diagnostic Yield of Echocardiography in Transient Ischemic Attack.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 25(5):1135-1140 [DOI] 10.1016/j.jstrokecerebrovasdis.2016.01.011. [PMID] 26915604.
2016
Source apportionment of atmospheric polycyclic aromatic hydrocarbons (PAHs) in Palm Beach County, Florida.
Journal of the Air & Waste Management Association (1995). 66(4):377-86 [DOI] 10.1080/10962247.2016.1138902. [PMID] 26745031.
2016
Visuospatial Neglect from Stroke Causing a Motor Vehicle Collision.
The Journal of emergency medicine. 50(4):e195-6 [DOI] 10.1016/j.jemermed.2015.11.009. [PMID] 26803188.
2013
Convergent validity and interrater reliability of estimating the ABCD2 score from medical records.
Stroke. 44(3):803-5 [DOI] 10.1161/STROKEAHA.112.675611. [PMID] 23339964.
2010
Combined optic neuropathy and myelopathy secondary to copper deficiency.
Survey of ophthalmology. 55(4):386-92 [DOI] 10.1016/j.survophthal.2010.02.002. [PMID] 20451943.
2003
Distinct presenilin-dependent and presenilin-independent gamma-secretases are responsible for total cellular Abeta production.
Journal of neuroscience research. 74(3):361-9 [PMID] 14598312.
2003
GSK-3alpha regulates production of Alzheimer’s disease amyloid-beta peptides.
Nature. 423(6938):435-9 [PMID] 12761548.
2002
Presenilins are not required for A beta 42 production in the early secretory pathway.
Nature neuroscience. 5(9):849-55 [PMID] 12145638.

Grants

Dec 2019 ACTIVE
A Global, Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of BMS-986177, an Oral Factor XIa Inhibitor, for the Prevention of New Ischemic Stroke or New Covert Brain Infarction in Patients Receiving Aspirin and Clopidogrel Following Acute Ischemic Stroke or Transient Ischemic Attack (TIA)
Role: Principal Investigator
Funding: PPD INVESTIGATOR SERVICES LLC via BRISTOL MYERS SQUIBB CO
Jul 2019 ACTIVE
ARCADIA CSI (Cognition and Silent Infarcts) "Study"
Role: Principal Investigator
Funding: UNIV OF CINCINNATI via NATL INST OF HLTH NINDS
Jun 2018 – Feb 2022
Multi-arm Optimization of Stroke Thrombolysis (MOST) Stroke Trial
Role: Project Manager
Funding: UNIV OF CINCINNATI via NATL INST OF HLTH NINDS
May 2017 ACTIVE
AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke (ARCADIA)
Role: Principal Investigator
Funding: UNIV OF CINCINNATI via NATL INST OF HLTH NINDS
Apr 2016 – Apr 2019
A MULTICENTER DOUBLE BLIND PLACEBO CONTROLLED RANDOMIZED PARALLEL GROUP DOSE RANGING STUDY TO EVALUATE THE SAFETY….
Role: Principal Investigator
Funding: IQVIA via BIOGEN MA INC
Dec 2015 – Dec 2018
AN EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY,TOLERABILITY & EFFICACY OF DALFAMPRIDINE EXTENDED-RELEASE TABLETS…
Role: Principal Investigator
Funding: IQVIA via ACORDA THERAPEUTICS
Apr 2015 – May 2017
DALF-PS-1016: A Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets for Treatment of Stable Walking Deficits in Post-Ischemic Stroke (MILESTONE).
Role: Principal Investigator
Funding: ACORDA THERAPEUTICS
Apr 2014 – Apr 2019
Mltictr, rdmzd,dble-blind,dble-dummy,actve-comparator,event-driven, superiority ph 3I stdy of sec. prevtn. of strke and prevtn of systematic embolism in pts/w a recent Embolic Stroke of Undtrmned Srce ,compring rivaroxaban 15 mg once dly w/aspirin 100 mg
Role: Principal Investigator
Funding: BAYER HEALTHCARE PHARMACEUTICALS

Education

Fellowship – Neurology
2013 · University of Pennsylvania
Residency – Neurology
2012 · University of Pennsylvania
Internship – Internal Medicine
2009 · Pennsylvania Hospital
Medical Degree
2008 · University of Pennsylvania
Doctoral Degree
2001 · University of Pennsylvania
Bachelors Degree
1995 · Furman University

Contact Details

Phones:
Business:
(352) 273-5550
Addresses:
Business Mailing:
PO Box 100236
GAINESVILLE FL 32610
Business Street:
NEWELL DRIVE
MCKNIGHT BRAIN INSTITUTE
GAINESVILLE FL 32606